Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. (CAPR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CAPR · as of Jun 8, 2026
Key Statistics
Explore Capricor Therapeutics, Inc. Data
capr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 100.0%
The CAPR analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $48.75, representing +83.58% upside from the current price of $26.55.
Competitors & Peers
capr competitorsCAPR
ACHV
ALLO
ARCT
CABA
EDITStock Performance
Full HistoryAbout Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of di…
what is capricor therapeutics, inc. · capr stock overview · capricor therapeutics, inc. company profile · who is capricor therapeutics, inc. ceo · capr NASDAQ · capricor therapeutics, inc. headquarters · capricor therapeutics, inc. business segments
About Stock Overview & Key Data
Capricor Therapeutics, Inc. (CAPR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 13, 2007. As of the latest trading session, CAPR stock price is $26.55, with a market capitalization of $1.2B. The stock has returned +98.24% over the past 12 months and -8.09% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Capricor Therapeutics, Inc. stock is Buy, with an average 12-month price target of $48.75. In fiscal year 2025, Capricor Therapeutics, Inc. reported revenue of — and net income of -$105.0M. For detailed data — including Capricor Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Capricor Therapeutics, Inc. (CAPR) stock price is $26.55. The stock is traded on NASDAQ under the ticker symbol CAPR. The 52-week range is $4.30 – $40.37.